SMTL ID : 3fqe.1

Crystal structure of spleen tyrosine kinase complexed with YM193306

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x P5C: 2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide(Non-covalent)

P5C.1: 18 residues within 4Å: Chain A: L.25, S.27, V.33, A.48, K.50, V.81, M.96, E.97, M.98, A.99, E.100, G.102, P.103, R.146, N.147, L.149, S.159, D.160 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.25, A:V.33, A:V.33, A:L.149 Hydrogen bonds: A:E.97, A:A.99, A:S.159, A:D.160, A:D.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Villasenor, A.G. et al., Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes. Chem.Biol.Drug Des. (2009)

Release Date

2009-03-10

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence